MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Literature Review

References

1. 1.↵
   1. Helms J,
   2. Kremer S,
   3. Merdji H, et al

   . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:32294339

   CrossRefPubMed
2. 2.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020 April 10. [Epub ahead of print] doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
3. 3.↵
   1. Cucinotta D,
   2. Vanelli M

   . WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157–60 doi:10.23750/abm.v91i1.9397 pmid:32191675

   CrossRefPubMed
4. 4.↵
   1. Modjarrad K,
   2. Moorthy VS,
   3. Millett P, et al

   . Developing global norms for sharing data and results during public health emergencies. PLoS Med 2016;13:e1001935 doi:10.1371/journal.pmed.1001935 pmid:26731342

   CrossRefPubMed
5. 5.↵
   1. Li X,
   2. Qian Y,
   3. Liu B, et al

   . Helping the radiologist: the role of scientific journals to help prevent the spread of COVID-19. Radiology 2020;295:E4 doi:10.1148/radiol.2020200661 pmid:32125934

   CrossRefPubMed
6. 6.↵
   1. Kandemirli SG,
   2. Dogan L,
   3. Sarikaya ZT, et al

   . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020 May 8. [Epub ahead of print] doi:10.1148/radiol.2020201697 pmid:32384020

   CrossRefPubMed
7. 7.↵
   1. Radmanesh A,
   2. Derman A,
   3. Lui YW, et al

   . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020202040 pmid:32437314

   CrossRefPubMed
8. 8.↵
   1. Mahammedi A,
   2. Saba L,
   3. Vagal A, et al

   . Imaging in neurological disease of hospitalized patients with COVID-19: an Italian multicenter retrospective observational study. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020201933 pmid:32437313

   CrossRefPubMed
9. 9.↵
   1. Helms J,
   2. Tacquard C,
   3. Severac F, et al

   ; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1089–98 doi:10.1007/s00134-020-06062-x

   CrossRefPubMed
10. 10.↵
    1. Jain R,
    2. Young M,
    3. Dogra S, et al

    . COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020;414:116923 doi:10.1016/j.jns.2020.116923 pmid:32447193

    CrossRefPubMed
11. 11.↵
    1. Radmanesh A,
    2. Raz E,
    3. Zan E, et al

    . Brain imaging use and findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol 2020;41:1179–83 doi:10.3174/ajnr.A6610 pmid:32467191

    Abstract/FREE Full Text
12. 12.↵
    1. Oxley TJ,
    2. Mocco J,
    3. Majidi S, et al

    . Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med 2020;382:e60 doi:10.1056/NEJMc2009787 pmid:32343504

    CrossRefPubMed
13. 13.↵
    1. Hughes C,
    2. Nichols T,
    3. Pike M, et al

    . Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 2020;7:001691 doi:10.12890/2020_001691 pmid:32399457

    CrossRefPubMed
14. 14.↵
    1. Bikdeli B,
    2. Madhavan MV,
    3. Jimenez D, et al

    ; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73 doi:10.1016/j.jacc.2020.04.031 pmid:32311448

    FREE Full Text
15. 15.↵
    1. Zamora CA,
    2. Nauen D,
    3. Hynecek R, et al

    . Delayed posthypoxic leukoencephalopathy: a case series and review of the literature. Brain Behav 2015;5:e00364 doi:10.1002/brb3.364 pmid:26357591

    CrossRefPubMed
16. 16.↵
    1. Nicholson P,
    2. Alshafai L,
    3. Krings T

    . Neuroimaging findings in patients with COVID-19. AJNR Am J Neuroradiol 2020 June 11. [Epub ahead of print] doi:10.3174/ajnr.A6630 pmid:32527843

    Abstract/FREE Full Text
17. 17.↵
    1. Ellchuk TN,
    2. Shah LM,
    3. Hewlett RH, et al

    . Suspicious neuroimaging pattern of thrombotic microangiopathy. AJNR Am J Neuroradiol 2011;32:734–38 doi:10.3174/ajnr.A2351 pmid:21292795

    Abstract/FREE Full Text
18. 18.↵
    1. Hawley JS,
    2. Ney JP,
    3. Swanberg MM

    . Thrombotic thrombocytopenic purpura-induced posterior leukoencephalopathy in a patient without significant renal or hypertensive complications. J Postgrad Med 2004;50:197–99

    PubMed
19. 19.↵
    1. Ye Q,
    2. Wang B,
    3. Mao J

    . The pathogenesis and treatment of the “cytokine storm” in COVID-19. J Infect 2020;80:607–13 doi:10.1016/j.jinf.2020.03.037 pmid:32283152

    CrossRefPubMed
20. 20.↵
    1. Mehta P,
    2. McAuley DF,
    3. Brown M

    , et al. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–34 doi:10.1016/S0140-6736(20)30628-0 pmid:32192578

    CrossRefPubMed
21. 21.↵
    1. Teijaro JR,
    2. Walsh KB,
    3. Cahalan S, et al

    . Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011;146:980–91 doi:10.1016/j.cell.2011.08.015 pmid:21925319

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Haktanir A

    . MR imaging in novel influenza A(H1N1)-associated meningoencephalitis. AJNR Am J Neuroradiol 2010;31:394–95 doi:10.3174/ajnr.A2037 pmid:20150309

    Abstract/FREE Full Text
23. 23.↵
    ACR Guidance on COVID-19 and MR Use. https://www.acr.org/Clinical-Resources/Radiology-Safety/MR-Safety/COVID-19-and-MR-Use. Accessed May 31, 2020
24. 24.
    1. Dogan L,
    2. Kaya D,
    3. Sarikaya T, et al

    . Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series. Brain Behav Immun 2020;87:155–58 doi:10.1016/j.bbi.2020.05.022 pmid:32389697

    CrossRefPubMed
25. 25.
    1. Tunç A,
    2. Ünlübaş Y,
    3. Alemdar M, et al

    . Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci 2020;77:227–29 doi:10.1016/j.jocn.2020.05.018 pmid:32409210

    CrossRefPubMed
26. 26.
    1. Beyrouti R,
    2. Adams ME,
    3. Benjamin L, et al

    . Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 2020;91:889–91 doi:10.1136/jnnp-2020-323586 pmid:32354768

    FREE Full Text
27. 27.
    1. Franceschi AM,
    2. Ahmed O,
    3. Giliberto L, et al

    . Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol 2020;41:1173–76 doi:10.3174/ajnr.A6595 pmid:32439646

    Abstract/FREE Full Text
28. 28.
    1. Cavalcanti DD,
    2. Raz E,
    3. Shapiro M, et al

    . Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol 2020 June 18. [Epub ahead of print] doi:10.3174/ajnr.A6644] pmid:32554424

    CrossRefPubMed
29. 29.
    1. Moriguchi T,
    2. Harii N,
    3. Goto J, et al

    . A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 2020;94:55–58 doi:10.1016/j.ijid.2020.03.062 pmid:32251791

    CrossRefPubMed
30. 30.
    1. Sachs JR,
    2. Gibbs KW,
    3. Swor DE, et al

    . COVID-19-associated leukoencephalopathy. Radiology 2020 May14. [Epub ahead of print] doi:10.1148/radiol.2020201753 pmid:32407258

    CrossRefPubMed
31. 31.
    1. Pilotto A,
    2. Odolini S,
    3. Masciocchi S, et al

    . Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol 2020 May17. [Epub ahead of print] doi:10.1002/ana.25783 pmid:32418288

    CrossRefPubMed
32. 32.
    1. Poyiadji N,
    2. Shahin G,
    3. Noujaim D, et al

    . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;296:E119–20 doi:10.1148/radiol.2020201187 pmid:32228363

    CrossRefPubMed
33. 33.
    1. Wong PF,
    2. Craik S,
    3. Newman P, et al

    . Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med 2020;20:293–94 doi:10.7861/clinmed.2020-0182 pmid:32371417

    Abstract/FREE Full Text
34. 34.
    1. Zanin L,
    2. Saraceno G,
    3. Panciani PP, et al

    . SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020;162:1491–94 doi:10.1007/s00701-020-04374-x pmid:32367205

    CrossRefPubMed
35. 35.
    1. Kaya Y,
    2. Kara S,
    3. Akinci C, et al

    . Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: case report. J Neurol Sci 2020;413:116858 doi:10.1016/j.jns.2020.116858 pmid:32387762

    CrossRefPubMed
36. 36.
    1. Laurendon T,
    2. Radulesco T,
    3. Mugnier J, et al

    . Bilateral transient olfactory bulbs edema during COVID-19-related anosmia. Neurology 2020;95:224–25 doi:10.1212/WNL.0000000000009850 pmid:32444492

    Abstract/FREE Full Text
37. 37.
    1. Chougar L,
    2. Mathon B,
    3. Weiss N, et al

    . Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. AJNR Am J Neuroradiol 2020 June18. [Epub ahead of print] doi:10.3174.ajnr.A6642 pmid:32554423

    Abstract/FREE Full Text
38. 38.
    1. Avula A,
    2. Nalleballe K,
    3. Narula N, et al

    . COVID-19 presenting as stroke. Brain Behav Immun 2020;87:115–19 doi:10.1016/j.bbi.2020.04.077 pmid:32360439

    CrossRefPubMed
39. 39.
    1. Politi LS,
    2. Salsano E,
    3. Grimaldi M

    . Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020 May 29. [Epub ahead of print] doi:10.1001/jamaneurol.2020.2125 pmid:32469400

    CrossRefPubMed